Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (151-160 of 227) with videos related to

Pageof 23
Sort By:
The Journal of Experimental Medicine|July 13, 2018
miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potentialSara E Meyer, David E Muench, Andrew M Rogers, et al.
Blood|July 2, 2013
Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphomaScott R P McDonnell, Steven R Hwang, Delphine Rolland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Cell Systems|June 22, 2023
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomicsDavid B Morse, Aleksandra M Michalowski, Michele Ceribelli, et al.
Journal of Medicinal Chemistry|September 19, 2009
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasisGanesha Rai, Ahmed A Sayed, Wendy A Lea, et al.
Molecular Cancer Therapeutics|August 10, 2019
Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like PhenotypeYansong Bian, Yaroslav Teper, Lesley A Mathews Griner, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicityMichele Ceribelli, Frances Anne Tosto, Xiaohu Zhang, et al.
Journal of Medicinal Chemistry|November 14, 2009
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatBBryan T Mott, Rafaela S Ferreira, Anton Simeonov, et al.
Leukemia|July 16, 2025
Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilizationEric J Vick, Aishlin Hassan, Kwangmin Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Pageof 23

Showing results (151-160 of 227) with videos related to

Sort By:
Pageof 23
The Journal of Experimental Medicine|July 13, 2018
miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potentialSara E Meyer, David E Muench, Andrew M Rogers, et al.
Blood|July 2, 2013
Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphomaScott R P McDonnell, Steven R Hwang, Delphine Rolland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Cell Systems|June 22, 2023
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomicsDavid B Morse, Aleksandra M Michalowski, Michele Ceribelli, et al.
Journal of Medicinal Chemistry|September 19, 2009
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasisGanesha Rai, Ahmed A Sayed, Wendy A Lea, et al.
Molecular Cancer Therapeutics|August 10, 2019
Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like PhenotypeYansong Bian, Yaroslav Teper, Lesley A Mathews Griner, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicityMichele Ceribelli, Frances Anne Tosto, Xiaohu Zhang, et al.
Journal of Medicinal Chemistry|November 14, 2009
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatBBryan T Mott, Rafaela S Ferreira, Anton Simeonov, et al.
Leukemia|July 16, 2025
Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilizationEric J Vick, Aishlin Hassan, Kwangmin Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Pageof 23